株式会社シンプロジェン

What it does

"Synplogen is a deeptech company that specializes in unique DNA synthesis technologies developed by Kobe University and other research institutions. Established in 2017, Synplogen leverages its proprietary DNA synthesis methods, OGAB® and Combinatorial-OGAB, to offer services in DNA synthesis, DNA library construction, and gene therapy. The company operates a biofoundry dedicated to gene therapy, providing design, development, and analysis services for gene therapy products such as viral vectors. With the ability to synthesize DNA up to 100kbp in length and handle complex sequences with varying GC content and repeat patterns, Synplogen is at the forefront of challenging DNA synthesis tasks. Collaborating with GMP-compliant manufacturing partners globally, Synplogen ensures a seamless development and manufacturing value chain for gene therapy products, facilitating early clinical trials and practical applications in the field of genetic medicine."